NDC 60763-601

PURINETHOL

Mercaptopurine

PURINETHOL is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Stason Pharmaceuticals, Inc.. The primary component is Mercaptopurine.

Product ID60763-601_107943c8-e56e-454b-a876-2cf5760c3f73
NDC60763-601
Product TypeHuman Prescription Drug
Proprietary NamePURINETHOL
Generic NameMercaptopurine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2021-01-15
Marketing CategoryNDA / NDA
Application NumberNDA009053
Labeler NameStason Pharmaceuticals, Inc.
Substance NameMERCAPTOPURINE
Active Ingredient Strength50 mg/1
Pharm ClassesNucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 60763-601-13

25 TABLET in 1 BOTTLE, PLASTIC (60763-601-13)
Marketing Start Date2021-01-15
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "PURINETHOL" or generic name "Mercaptopurine"

NDCBrand NameGeneric Name
60763-601PURINETHOLMercaptopurine
0054-4581MercaptopurineMercaptopurine
0378-3547Mercaptopurinemercaptopurine
49884-922mercaptopurinemercaptopurine
69076-913MercaptopurineMercaptopurine

Trademark Results [PURINETHOL]

Mark Image

Registration | Serial
Company
Trademark
Application Date
PURINETHOL
PURINETHOL
77140307 3391060 Dead/Cancelled
STASON PHARMACEUTICALS, INC.
2007-03-26
PURINETHOL
PURINETHOL
71647991 0587330 Live/Registered
BURROUGHS WELLCOME & CO. (U. S. A.) INC.
1953-06-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.